Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery

American Journal of Cardiology

Volumn 98, Issue 3, 2006, Pages 362-366

  Stankovic, Goran ^c   Cosgrave, John ^a   Chieffo, Alaide ^a,b   Iakovou, Ioannis ^a   Sangiorgi, Giuseppe ^a   Montorfano, Matteo ^b   Airoldi, Flavio ^b   Carlino, Mauro ^b   Michev, Iassen ^b   Finci, Leo ^a   Colombo, Antonio ^a,b  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEMOGRAPHY; DIABETIC PATIENT; DISEASE DURATION; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAMPLE SIZE; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ODDS RATIO; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33745966706     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.104     Document Type: Article

References (16)

1. Flaherty J.D., and Davidson C.J. Diabetes and coronary revascularization. JAMA 293 (2005) 1501-1508
2. Prasad A., Stone G.W., Stuckey T.D., Costantini C.O., Zimetbaum P.J., McLaughlin M., Mehran R., Garcia E., Tcheng J.E., Cox D.A., Grines C.L., Lansky A.J., and Gersh B.J. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 45 (2005) 508-514
3. West N.E., Ruygrok P.N., Disco C.M., Webster M.W., Lindeboom W.K., O'Neill W.W., Mercado N.F., and Serruys P.W. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 109 (2004) 867-873
4. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., and Stone G.W. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
5. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., Kuntz R.E., and Moses J.W. Impact of sirolimus-eluting stents on outcome in diabetic patients. a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
6. Orlic D., Bonizzoni E., Stankovic G., Airoldi F., Chieffo A., Corvaja N., Sangiorgi G., Ferraro M., Briguori C., Montorfano M., Carlino M., and Colombo A. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation. immediate and mid-term results. J Am Coll Cardiol 43 (2004) 1154-1160
7. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
8. Serruys P., Ong A., Morice M.C., De Bruyne B., Colombo A., Macaya C., Richardt G., Fajadet J., Hamm C.W., Dawkins K., O'Malley J., Bressers M., Donohoe D., and ARTS II Investigators. Arterial Revascularisation Therapies Study Part II-sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroInterv 1 (2005) 147-156
9. Windecker S., Remondino A., Eberli F.R., Juni P., Raber L., Wenaweser P., Togni M., Billinger M., Tuller D., Seiler C., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
10. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., and Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
11. Goy J.J., Stauffer J.C., Siegenthaler M., Benoit A., and Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology. the TAXi trial. J Am Coll Cardiol 45 (2005) 308-311
12. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., and Schomig A. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. a randomized controlled trial. JAMA 293 (2005) 165-171
13. de Lezo J., Medina A., Pan M., Romero M., Delgado A., Segura J., Hernandez E., Pavlovic D.J., Ojeda S., Segura J., et al. Drug-eluting stents for complex lesions. randomized rapamycin versus paclitaxel CORPAL study. (abstr). J Am Coll Cardiol 45 (2005) 75A-76A
14. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., and Stoll H.P. Sirolimus vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
15. Ong A.T., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Valgimigli M., Tsuchida K., Sonnenschein K., Regar E., van der Giessen W.J., de Jaegere P.P., et al. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol 96 (2005) 358-362
16. Briguori C., Condorelli G., Airoldi F., Mikhail G.W., Ricciardelli B., and Colombo A. Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients. Heart 90 (2004) 1481-1482